Abstract:To determine whether protein tyrosine kinase (PTK) modulates volume-sensitive chloride current (ICl.vol) in human atrial myocytes and to identify the PTKs involved, we studied the effects of broad-spectrum and selective PTK inhibitors and the protein tyrosine phosphatase (PTP) inhibitor orthovanadate (VO4−3). ICl.vol evoked by hyposmotic bath solution (0.6-times isosmotic, 0.6T) was enhanced by genistein, a broad-spectrum PTK inhibitor, in a concentration-dependent manner (EC50 = 22.4 μM); 100 μM genistein stimulated ICl.vol by 122.4 ± 10.6%. The genistein-stimulated current was inhibited by DIDS (4,4′-diisothiocyanostilbene-2,2′-disulfonic acid, 150 μM) and tamoxifen (20 μM), blockers of ICl.vol. Moreover, the current augmented by genistein was volume dependent; it was abolished by hyperosmotic shrinkage in 1.4T, and genistein did not activate Cl− current in 1T. In contrast to the stimulatory effects of genistein, 100 μM tyrphostin A23 (AG 18) and A25 (AG 82) inhibited ICl.vol by 38.2 ± 4.9% and 40.9 ± 3.4%, respectively. The inactive analogs, daidzein and tyrphostin A63 (AG 43), did not alter ICl.vol. In addition, the PTP inhibitor VO4−3 (1 mM) reduced ICl.vol by 53.5 ± 4.5% (IC50 = 249.6 μM). Pretreatment with VO4−3 antagonized genistein-induced augmentation and A23- or A25-induced suppression of ICl.vol. Furthermore, the selective Src-family PTK inhibitor PP2 (5 μM) stimulated ICl.vol, mimicking genistein, whereas the selective EGFR (ErbB-1) kinase inhibitor tyrphostin B56 (AG 556, 25 μM) reduced ICl.vol, mimicking A23 and A25. The effects of both PP2 and B56 also were substantially antagonized by pretreatment with VO4−3. The results suggest that ICl.vol is regulated in part by the balance between PTK and PTP activity. Regulation is complex, however. Src and EGFR kinases, distinct soluble and receptor-mediated PTK families, have opposing effects on ICl.vol, and multiple target proteins are likely to be involved.

Epidermal Growth Factor Receptor Tyrosine Kinase Stimulates Human Inward Rectifier Potassium (kir2.3) Channels

Epidermal Growth Factor Receptor Tyrosine Kinase Regulates the Human Inward Rectifier Potassium K(Ir)2.3 Channel, Stably Expressed in Hek 293 Cells

Genistein and Tyrphostin AG556 Inhibit Inwardly-Rectifying Kir2.1 Channels Expressed in HEK 293 Cells Via Protein Tyrosine Kinase Inhibition

Both EGFR Kinase and Src-related Tyrosine Kinases Regulate Human Ether-À-go-go-related Gene Potassium Channels.

EGFR Tyrosine Kinase Regulates Human Small-Conductance Ca2+-activated K+ (hskca1) Channels Expressed in HEK-293 Cells.

Modulation of Human Cardiac Transient Outward Potassium Current by Egfr Tyrosine Kinase and Src-Family Kinases

Tyrphostin AG556 Increases the Activity of Large Conductance Ca2+‐activated K+ Channels by Inhibiting Epidermal Growth Factor Receptor Tyrosine Kinase

Genistein and Tyrphostin AG556 Decrease Ultra‐rapidly Activating Delayed Rectifier K+ Current of Human Atria by Inhibiting EGF Receptor Tyrosine Kinase

Activation of epidermal growth factor receptor inhibits KCNQ2/3 current through two distinct pathways: membrane PtdIns(4,5)P2 hydrolysis and channel phosphorylation.

Activation of Epidermal Growth Factor Receptor Inhibits KCNQ2/3 Current through Two Distinct Pathways: Membrane PtdIns(4,5)P<sub>2</sub>Hydrolysis and Channel Phosphorylation

Regulation of Transient Outward Current in Human Atrial Myocytes by Protein Tyrosine Kinase Pathway

The calcium-dependent activity of large-conductance, calcium-activated K+ channels is enhanced by Pyk2- and Hck-induced tyrosine phosphorylation.

Human Kir2.1 Channel Carries a Transient Outward Potassium Current with Inward Rectification

Transforming Activity of Receptor Tyrosine Kinase Tyro3 is Mediated, at Least in Part, by the PI3 Kinase-Signaling Pathway

Human Cardiac Inwardly-Rectifying K + Channel Kir 2.1b is Inhibited by Direct Protein Kinase C-Dependent Regulation in Human Isolated Cardiomyocytes and in an Expression System

Molecular Mechanism of Inward Rectifier Potassium Channel 2.3 Regulation by Tax-Interacting Protein-1

Inhibitory Actions of the Phosphatidylinositol 3-Kinase Inhibitor LY294002 on the Human Kv1.5 Channel.

Deletion of Protein Kinase A Phosphorylation Sites in the Herg Potassium Channel Inhibits Activation Shift by Protein Kinase A

Differential Effects of Tyrosine Kinase Inhibitors on Volume-sensitive Chloride Current in Human Atrial Myocytes

Requirement of Tyr-992 and Tyr-1173 in phosphorylation of the epidermal growth factor receptor by ionizing radiation and modulation by SHP2

Tissue kallikrein mediates neurite outgrowth through epidermal growth factor receptor and flotillin-2 pathway in vitro